Terms: = Colorectal cancer AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4 AND Prognosis
13 results:
1. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
Lu X; Li Y; Li Y; Zhang X; Shi J; Feng H; Yu Z; Gao Y
BMC Cancer; 2023 Nov; 23(1):1117. PubMed ID: 37974093
[TBL] [Abstract] [Full Text] [Related]
2. Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract.
Wu H; Yu Z; Liu Y; Guo L; Teng L; Guo L; Liang L; Wang J; Gao J; Li R; Yang L; Nie X; Su D; Liang Z
Cancer Commun (Lond); 2022 Dec; 42(12):1367-1386. PubMed ID: 36264285
[TBL] [Abstract] [Full Text] [Related]
3. her4 promotes the progression of colorectal cancer by promoting epithelial‑mesenchymal transition.
Jia X; Wang H; Li Z; Yan J; Guo Y; Zhao W; Gao L; Wang B; Jia Y
Mol Med Rep; 2020 Apr; 21(4):1779-1788. PubMed ID: 32319604
[TBL] [Abstract] [Full Text] [Related]
4. Clinical significance of multiple gene detection with a 22-gene panel in formalin-fixed paraffin-embedded specimens of 207 colorectal cancer patients.
Gao XH; Yu GY; Hong YG; Lian W; Chouhan H; Xu Y; Liu LJ; Bai CG; Zhang W
Int J Clin Oncol; 2019 Feb; 24(2):141-152. PubMed ID: 30612269
[TBL] [Abstract] [Full Text] [Related]
5. Ligand-Independent Epidermal Growth Factor Receptor Overexpression Correlates with Poor prognosis in colorectal cancer.
Yun S; Kwak Y; Nam SK; Seo AN; Oh HK; Kim DW; Kang SB; Lee HS
Cancer Res Treat; 2018 Oct; 50(4):1351-1361. PubMed ID: 29361822
[TBL] [Abstract] [Full Text] [Related]
6. HER3 expression is correlated to distally located and low-grade colon cancer.
Lédel F; Stenstedt K; Hallström M; Ragnhammar P; Edler D
Acta Oncol; 2016 Jul; 55(7):875-80. PubMed ID: 26863446
[TBL] [Abstract] [Full Text] [Related]
7. Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer.
Mitsui K; Yonezawa M; Tatsuguchi A; Shinji S; Gudis K; Tanaka S; Fujimori S; Sakamoto C
BMC Cancer; 2014 Nov; 14():863. PubMed ID: 25416285
[TBL] [Abstract] [Full Text] [Related]
8. Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer.
Szmida E; Karpiński P; Leszczynski P; Sedziak T; Kielan W; Ostasiewicz P; Sasiadek MM
J Appl Genet; 2015 May; 56(2):185-92. PubMed ID: 25366420
[TBL] [Abstract] [Full Text] [Related]
9. Co-expression of HER family members in patients with Dukes' C and D colon cancer and their impacts on patient prognosis and survival.
Khelwatty SA; Essapen S; Bagwan I; Green M; Seddon AM; Modjtahedi H
PLoS One; 2014; 9(3):e91139. PubMed ID: 24609222
[TBL] [Abstract] [Full Text] [Related]
10. Investigational therapies targeting the ErbB (EGFR, HER2, HER3, her4) family in GI cancers.
Desai MD; Saroya BS; Lockhart AC
Expert Opin Investig Drugs; 2013 Mar; 22(3):341-56. PubMed ID: 23316969
[TBL] [Abstract] [Full Text] [Related]
11. ErbB family immunohistochemical expression in colorectal cancer patients with higher risk of recurrence after radical surgery.
Baiocchi G; Lopes A; Coudry RA; Rossi BM; Soares FA; Aguiar S; Guimarães GC; Ferreira FO; Nakagawa WT
Int J Colorectal Dis; 2009 Sep; 24(9):1059-68. PubMed ID: 19390858
[TBL] [Abstract] [Full Text] [Related]
12. Access to care, socioeconomic deprivation and colon cancer survival.
Dejardin O; Bouvier AM; Faivre J; Boutreux S; De Pouvourville G; Launoy G
Aliment Pharmacol Ther; 2008 May; 27(10):940-9. PubMed ID: 18315583
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic significance of HER3 and her4 protein expression in colorectal adenocarcinomas.
Kountourakis P; Pavlakis K; Psyrri A; Rontogianni D; Xiros N; Patsouris E; Pectasides D; Economopoulos T
BMC Cancer; 2006 Feb; 6():46. PubMed ID: 16507107
[TBL] [Abstract] [Full Text] [Related]
